from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3011c/gatA

LFCtreatmentdescriptionclass of inhibitor

0.383

Amikacinug/mL Amikacintranslation

-0.072

Cap5-10ug/mL Capreomycintranslation

-0.657

Rox10-50 ug/mL Roxithromycintranslation

0.032

SM2-5 ug/mL Streptomycintranslation

1.232

Tet5-10 ug/mL Tetracyclinetranslation

0.995

Rif0.2-5ug/mL Rifampicintranscription

0.849

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.669

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.159

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.347

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.632

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.231

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.681

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.497

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.003

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.192

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.652

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.677

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.855

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.386

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.137

KCN5-20 ug/mL Potassium cyaniderespiration

0.101

NaN30.2-2 mM Sodium aziderespiration

0.171

Nigericin50 uM Nigericinrespiration

-0.043

TRC10-150 ug/mL Triclosanrespiration

-1.776

TRZ10-25 ug/mL Thioridazinerespiration

-1.359

Valinomycin0.5-10 uM Valinomycinrespiration

-0.168

ZnSO42 mM ZnSO4respiration

1.068

menadione6-10 ug/mL Menadionerespiration

-0.316

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.385

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.219

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.684

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.299

NRP_1Non-replicating persistence stage 1dosRassociated

0.319

Amp0.2mg/mL AmpicillincellWall

0.407

Cephalexin20-100 ug/mL CephalexincellWall

0.729

Cerulenin0.32-5 ug/mL CerulenincellWall

0.324

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.228

EMB10-20 ug/mL EthambutolcellWall

0.209

Eta12-40 ug/mL EthionamidecellWall

0.801

INH0.2-0.4 ug/mL IsoniazidcellWall

0.632

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.026

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.778

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.324

BZA0.12 mg/mL BenzamidearomaticAmides

0.199

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.337

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.183

H2O24 mM hydrogen peroxideDNAdamaging

0.582

Levo10 ug/mL LevofloxacinDNAdamaging

0.859

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.069

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.011

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.802

UVUV-irradiationDNAdamaging

-1.518

ARP41-4 ug/mL Antitubercular compound ARP4?

0.568

Antimycin12.5-50 ug/mL Antimycin A?

0.264

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.295

PA_110-50 ug/mL Antitubercular compound PA-1?

0.342

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.501

PA8240.2-2 ug/mL PA-824?

-0.942

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.258

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.113

Verapamil50 uM Verapamil?

0.083

mercaptoethanol2 mM 2-Mercaptoethanol?

0.593

methoxatin10-20 ug/mL Methoxatin?